News about our Companies - MedTech Innovator

Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World

DateMay 29 2020

"The current crisis has shown us the necessity of a different approach to providing healthcare, where technology and AI are crucial for future success. Arterys is committed to transforming the way AI is integrated into the medical workflow, a promise that is long due in the industry. We recently launched our cloud platform and marketplace that will consolidate the work of thousands of AI models to be readily available for use by healthcare institutions around the globe," said Henry Weinstein, Managing Partner at Benslie International Ltd.

PercuSense Secures DoD Funds for Chemical Exposure Monitoring Tech Dev’t

DateMay 29 2020

The company said Thursday it will use the funds awarded by the Defense Innovation Unit and the Defense Threat Reduction Agency to produce the on-body platform for first responders and military personnel to receive exposure alerts in real time.

Medtech Startup Promaxo Raises First Tranche of Series B-1 Funding

DateMay 28 2020

Promaxo, an Oakland-based medical technology startup developing the portable single-sided MRI, today announced that it has raised the first tranche of Series B-1 funding. The equity round was led by Kineticos Disruptor Fund with participation from existing investors. Launched in 2016, Promaxo plans to revolutionize healthcare with its MR imaging and robotic platform.

Neural Analytics aims robotic transcranial doppler at COVID-19 patients

DateMay 28 2020

Doctors are reporting a proliferation of dangerous blood clots in the lungs and other major organs of COVID-19 patients, raising the risk of stroke and other life-threatening complications. While anticoagulant medications can reduce that risk, patients need careful monitoring to ensure their blood is neither too thick nor too thin. To that end, Los Angeles-based startup Neural Analytics Inc. is deploying its robotically assisted transcranial doppler (TCD) system for real-time identification of blood clots and disruptions in blood flow to the brain.

FDA greenlights ICU AI for predicting fatal COVID-19 complications

DateMay 28 2020

The company’s CLEWICU artificial intelligence software ingests a large range of patient data by linking to electronic medical records, connected medical devices and vital sign monitors, with no need for additional data entry by ICU staff. The FDA also said the standalone CLEWICU software, based within the hospital or in the cloud, could help reduce contact between healthcare workers and COVID-19 patients through remote monitoring.

Bardy Diagnostics® Announces CE Mark Certification for 14-Day Carnation® Ambulatory Monitor (CAM®) Patch in Europe and Expansion of Home Enrollment Program Amidst COVID-19 Crisis

DateMay 26 2020

"CE marking of the 14-Day CAM patch is a significant corporate milestone and a testament to the quality of the CAM patch and BardyDx's compliance with all applicable European health, safety, performance and environmental requirements," said Ed Vertatschitsch, Chief Operating Officer.

Alleviant Medical completes $6.5m offering

DateMay 19 2020

Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of $6.5 million in an equity offering. The Austin, Texas-based company reached its total offering amount of $6.5 million after making the first sale in the new notice on May 1. It had no intention of letting the offering last longer than one year and did not make it in connection with a business transaction.

PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

DateMay 19 2020

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova Corporation, the world's largest antibody manufacturer, based in Taiwan.